Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCHAL.L Regulatory News (CHAL)

  • There is currently no data for CHAL

Additional Resources

13 Jun 2017 07:00

RNS Number : 8584H
Challenger Acquisitions Limited
13 June 2017
 

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, WITHIN, INTO OR IN THE UNITED STATES, AUSTRALIA, CANADA OR JAPAN.

 

For immediate release 13 June 2017

Challenger Acquisitions Limited

("Challenger" or the "Company")

 

Additional Resources

 

Challenger Acquisitions Limited (LSE: CHAL) announces that it has received £100,000 (£95,000 net of fees) from the setup of a new £1,000,000 unsecured convertible note facility due 8 June 2019 ("Note Facility").

 

This Note Facility will be used for general working capital purposes and to potentially support an acquisition or development of a project to complement the Company's US$3 million equity interest in the US$590 million New York Wheel Project which is currently under construction.

 

Challenger has also engaged a London based consulting firm, on a success fee basis, to assist in identifying and securing project level funding sources for potential Giant Observation Wheel projects and for other new potential projects in the leisure and entertainment sectors which the Company is currently evaluating.

 

Mark Gustafson, the Company's Chief Executive Officer, said: "We are very pleased to have a funding facility in place and to be working on securing additional funding sources for potential new projects for Challenger.  Further updates will be provided in due course."

 

Principal terms of the Note Facility

· The aggregate principal amount is up to £1 million with a 24 month term.

· The convertible note is unlisted, unsecured, transferable and must be redeemed by the Company on 8 June 2019, in cash unless it has been fully converted by then into ordinary shares of the Company ("Ordinary Shares").

· There are no conversions for the first 120 days.

· The maximum amount that can be converted in any 30 day period is 20% of the principle amount.

· Subject to the conversion limitations noted above, the noteholder may exercise a conversion at the lowest volume weighted average price over the 10 days prior to the conversion ("Conversion Price").

· Interest is accrued at 8% per annum and payable upon conversion, at the Company's option in:

o cash; or

o by issuing Ordinary Shares in respect of such accrued interest conversion amount at the Conversion Price.

· At any time the Company can redeem in cash all or any part of the outstanding convertible note from the holder at a 25% premium to the principal amount of such notes.

· The convertible note may be redeemed by the noteholder following certain noteholder redemption events, which include: payment default; material breach by the Company not cured within fifteen trading days; the Company or any of its subsidiaries suffer an insolvency event.

· The convertible note and related documentation are governed under the laws of England.

 

This announcement contains inside information.

 

**ENDS**

 

For more information visit www.challengeracquisitions.com or enquire to:

 

Challenger Acquisitions Limited

 

Mark Gustafson

+1 604 454 8677

St Brides Partners Ltd (PR)

 

Lottie Brocklehurst, Charlotte Page

+44 (0) 20 7236 1177

 

 

 

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
UPDGGURPQUPMGAP
Date   Source Headline
14th Aug 20173:35 pmRNSHolding(s) in Company
11th Aug 201711:30 amRNSHolding(s) in Company
3rd Aug 201711:15 amRNSHolding(s) in Company
3rd Aug 201711:15 amRNSHolding(s) in Company
2nd Aug 20177:00 amRNSAllotment of Shares re Convertible Notes
31st Jul 20177:00 amRNSTotal Voting Rights
25th Jul 20177:00 amRNSNew York Wheel Construction Update
7th Jul 20177:01 amRNSDirector Dealings
7th Jul 20177:00 amRNSAllotment of Shares re Convertible Notes
5th Jul 201711:30 amRNSResult of AGM
29th Jun 201710:15 amRNSDirector Dealings
14th Jun 201710:00 amRNSNotice of AGM
13th Jun 20177:00 amRNSAdditional Resources
31st May 20177:00 amRNSTotal Voting Rights
25th May 20171:32 pmRNSAllotment of Shares re Convertible Notes
18th May 201710:15 amRNSConvertible Note
8th May 20177:00 amRNSMajor Amendments of Convertible Notes
4th May 201710:20 amRNSAllotment of Shares re Convertible Notes
28th Apr 20174:19 pmRNSFinal Results
12th Apr 201711:44 amRNSHolding(s) in Company
30th Mar 201710:45 amRNSAllotment of shares for convertible notes
29th Mar 20174:10 pmRNSHolding(s) in Company
28th Mar 201711:50 amRNSBoard Changes and Extension of Convertible Note
28th Feb 20177:00 amRNSTotal Voting Rights
9th Feb 20177:00 amRNSShareholder Conference Call
6th Feb 20177:00 amRNSCost Control Measures and Allotment of Shares
31st Jan 20177:00 amRNSTotal Voting Rights
30th Jan 20177:00 amRNSSale of Starneth with Consideration Agreement
6th Jan 20176:02 pmRNSReplacement: Allotment of Shares
6th Jan 20174:00 pmRNSAllotment of Shares re Convertible Loan Notes
6th Jan 20177:00 amRNSBoard of Director Change
19th Dec 20167:00 amRNSAllotment of Shares
20th Oct 20167:00 amRNSNew York Wheel Construction Update
18th Oct 20168:30 amRNSIssue of up to £0.35m in new convertible notes
12th Oct 20167:00 amRNSAllotment of Shares re Convertible Loan Notes
30th Sep 20167:00 amRNSTotal Voting Rights
12th Sep 20167:00 amRNSAllotment of Shares re Convertible Loan Notes
30th Aug 20167:00 amRNSInterim Results
25th Aug 20167:00 amRNSMadison Capital Markets LLC Court Case Dismissed
23rd Aug 20168:30 amRNSExtension Agreement with Starneth Vendors
29th Jul 20167:00 amRNSTotal Voting Rights
20th Jul 20167:00 amRNSUS$1 Million Received and New York Wheel Update
18th Jul 20165:08 pmRNSHolding(s) in Company
18th Jul 20162:10 pmRNSDirector Dealings
13th Jul 20167:00 amRNSAllotment of Shares
5th Jul 20167:00 amRNSManufacturing Facility Operational, Netherlands
27th Jun 20167:00 amRNSPurchase of Shares by Director
14th Jun 20167:00 amRNSIssue of new £0.5m convertible note
7th Jun 20167:00 amRNSPurchase of Shares by Director
26th May 20169:00 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.